(September 12, 2018, 1:35 PM EDT) -- CHICAGO — An Illinois appellate panel on Sept. 7 reversed and remanded a lower court’s ruling in a lead-based paint poisoning lawsuit, concluding that the plaintiffs have a valid cause of action for the reasonable value of testing services related to the injury from the paint, without regard to the fact that Medicaid paid the entire cost (Mary Lewis, et al. v. Lead Industries Association, et al., No. 1-17-2894, Ill. App., 1st Dist., 5th Div., 2018 IL App. LEXIS 647)....